Dr. Richard Bayney is a 23-year veteran of the Pharmaceutical & Biotechnology industry (Merck & Co, Bayer, Bristol-Myers Squibb, Johnson & Johnson), and the President & Founder of Project & Portfolio Value Creation (PPVC). He co-authored the book “Enterprise Project Portfolio Management; Building competencies for R&D and IT investment success”, and is adjunct faculty member at the University of Pennsylvania where he lectures to graduate and executive students in Project Portfolio Management.
Dr. Richard Bayney is President & Founder of Project & Portfolio Value Creation (PPVC), a consulting boutique providing training and education in Project, Program, Portfolio, Resource, and Risk Management as well as Business, Strategic, Portfolio, and Scenario Planning services. He is an adjunct faculty member at the University of Pennsylvania lecturing to graduate and executive students in ‘Project Portfolio Management.’ He delivers certification masterclasses on ‘Decision Analysis’ and ‘Portfolio Management’ in the US, EU, and Asia. Richard is a frequent speaker in ‘Portfolio & Resource Management, Risk Analysis & Risk Management, and Strategic Planning in Drug Development.’
Dr. Bayney is a 23-year veteran of the Pharmaceutical & Biotechnology industry at Merck & Co., Bayer Corp. and AG, Bristol-Myers Squibb, and Johnson & Johnson Pharmaceutical Research & Development. In his previous position at Johnson & Johnson, Richard was Vice President, Portfolio Management & Decision Analysis. He has spent 11 years building and leading departments in Strategic Planning, Decision Analysis, and Portfolio Management, 2 years as an International Project Manager for a marketed cardiovascular drug, and 10 years in Molecular Biology research into gene expression in drug detoxification systems and in Alzheimer’s Disease.
Dr. Bayney obtained his M.Sc. and Ph.D. from the University of London, MBA from Columbia University, and PMP from the Project Management Institute.